NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

OTC人工淚液市場成長機會、成長預測 (2021-2028年):產品類型、容器類型、製劑、用途、通路、各地區

OTC Artificial Tears Market by Product Type, Container Type, Formulation, Application, and Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2021--2028

出版商 Allied Market Research 商品編碼 1017298
出版日期 內容資訊 英文 376 Pages
商品交期: 2-3個工作天內
價格
OTC人工淚液市場成長機會、成長預測 (2021-2028年):產品類型、容器類型、製劑、用途、通路、各地區 OTC Artificial Tears Market by Product Type, Container Type, Formulation, Application, and Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2021--2028
出版日期: 2021年05月31日內容資訊: 英文 376 Pages
簡介

全球OTC人工淚液的市場規模在預測期間內預計以4.94%的年複合成長率發展,從2020年的43億7900萬美元,成長到2028年63億9943萬美元的規模。

老年人口增加,乾眼症症候群(DES)的盛行率大幅度上升,眼睛手術數量增加等要素促進該市場的成長。還有新產品開發的R&D投資,技術的進步,長時間接觸隱形眼鏡安裝者增加,數位顯示器等生活習慣的變化,智慧型手機中毒者劇增等要素推動市場成長。同時,由於OTC人工淚液的污染風險和防腐劑的副作用可能妨礙在預測期間內的市場成長。

本報告提供全球OTC人工淚液的市場調查,市場定義和概要,新型冠狀病毒感染疾病 (COVID-19) 以及其他的市場影響因素分析,市場規模的變化、預測,產品類型、容器類型、製劑、用途、通路、地區/主要國家等各種區分的明細,競爭環境,主要企業簡介等彙整資訊。

第1章 簡介

第2章 摘要整理

第3章 市場概要

  • 市場定義、範圍
  • 主要調查結果
  • 波特的五力分析
  • 市場佔有率分析、主要企業的地位
  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • COVID-19:影響分析

第4章 市場分析、預測:各產品類型

  • 解決方案
  • 軟膏
  • 乳劑
  • 凝膠
  • 噴霧解決方案
  • 懸浮液
    • 主要趨勢、成長要素、成長機會
    • 市場規模、預測:各地區
    • 市場佔有率分析:各國

第5章 市場分析、預測:各容器類型

  • 主要趨勢、成長要素、成長機會
  • 市場規模、預測:各地區
  • 市場佔有率分析:各國
  • 塑膠單劑量容器
  • 塑膠複數給藥容器
    • 無防腐劑系統
    • 保存系統
  • 噴霧
    • 不使用防腐劑系統
    • 保存系統

第6章 市場分析、預測:各製劑

  • 防腐劑為基礎
  • 不使用防腐劑為基礎
    • 主要趨勢、成長要素、成長機會
    • 市場規模、預測:各地區
    • 市場佔有率分析:各國

第7章 市場分析、預測:各用途

  • 乾眼症症候群
  • 過敏
  • 感染疾病
  • 紫外線、藍光的保護
  • 隱形眼鏡的水分保持
  • 其他
    • 主要趨勢、成長要素、成長機會
    • 市場規模、預測:各地區
    • 市場佔有率分析:各國

第8章 市場分析、預測:各銷售管道

  • 院內藥局
  • 藥妝店、零售藥局
  • 線上藥局
    • 主要趨勢、成長要素、成長機會
    • 市場規模、預測:各地區
    • 市場佔有率分析:各國

第9章 市場分析、預測:各地區、主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 中東、非洲

第10章 企業簡介

  • SANTEN PHARMACEUTICAL
  • BAUSCH & LOMB
  • ALLERGAN
  • ABBOTT LABORATORIES
  • JOHNSON & JOHNSON
  • LUMECARE
  • SIMILASAN CORPORATION
  • URSAPHARM
  • NOVARTIS AG(ALCON)
  • OCUSOFT
目錄
Product Code: A11343

The global OTC artificial tears market generated $4,379 million in 2020, and is projected to reach $6,399.43 million by 2028, growing at a CAGR of 4.94% from 2021 to 2028.

Artificial tears also known as ocular lubricants are eye drops that are used to lubricate dry eyes and maintain moisture on the outer surface of the eye for a longer duration of time. Over-the-counter (OTC) artificial tears are the products that are available directly to the consumer without prescription.

The global OTC artificial tears market is majorly driven by rise in geriatric population; an alarming increase in the prevalence of dry eye syndrome (DES); and a rise in the number of eye surgeries which increases the demand for artificial tear drops for post-surgery management. For instance, according to the World Health Organization (WHO), in 2021, approximately 2.2 billion population in the world was reported to be diagnosed with vision impairment. As per the data published in BioMed Central (BMC) Ophthalmology, in 2020, a total of 90% population across the globe suffered from dry eye syndrome. Moreover, the geriatric population is more vulnerable to dry eye syndrome due to inadequate tear production from lacrimal gland, altered reflex secretion or inflammatory destruction of the lacrimal glands. For instance, as per the data published by the Journal of the United Nations, 962 million population were present above the age of 60 years in 2017 which is expected to get double to nearly 2.1 billion by the year of 2050. Thus, the rise in the geriatric population and increase in prevalence of dry eye syndrome are expected to propel the demand for OTC artificial tears, which, in turn, augments the market growth. Furthermore, the increase in number of eye surgeries, upsurge the need of artificial tear drops for the post-surgical management.

Furthermore, OTC artificial tears play an important role in the global healthcare sector. Availability of different dosage forms of OTC artificial tears such as drops, ointment, emulsion, spray solution, and gel is used for providing relief from irritation, burning, and discomfort which is caused due to dry eye syndrome. Moreover, rise in investment and activities in R&D by various healthcare sectors for the development of new OTC artificial tears, such as REFRESH DIGITAL lubricant eye drop (AbbVie Inc.), drive the growth of the global market. Upsurge in technological advancement and rise in the number of people wearing contact lens, also increases the demand for OTC artificial tear and propel the growth of the market. In addition, change in the lifestyle habit such as prolong exposure to digital display and the surge in number of smartphone addicts, causes dry eye syndrome that increase the usage of artificial tears and boosts the market growth.

On the contrary, the risk of contamination associated with OTC artificial tears and adverse reaction due to presence of preservative in the formulations is anticipated to hinder the market growth during the forecast period. The adverse reactions caused due to use of artificial tear products include blurred vision, eye pain, skin rash, and redness around the eye.

The OTC artificial tears market is segmented into product type, container type, formulation, application, distribution channel and region. Depending on product type, the market is segmented into solution, ointment, emulsion, gel, spray solution and suspension. On the basis of container type, the market is fragmented into the plastic single dose container, plastic multi-dose container and spray. The plastic single dose container segment is further classified into preservative free system and preserved system. Further, the spray segment is further bifurcated into preservative free system and preserved system. On the basic of formulation, it is differentiated into preservative based and non-preservative based. By application, the global market is segregated into dry eye syndrome, allergies, infections, UV & blue light protection, contact lens moisture retention and others.

As per distribution channel, the market is classified into hospital pharmacies, drug stores & retail pharmacies, and online pharmacies. At regional level, the OTC artificial tears market is analyzed across North America, Europe, Asia-Pacific, Middle East, North-Africa and Rest of World.

The report provides an extensive competitive analysis and profiles of the key market players such as AbbVie, Inc., Akorn, Inc., Alcon, Bausch & Lomb, Johnson & Johnson, Ocusoft, Santen Pharmaceutical Co. Ltd, Similasan Corporation, Sun Pharmaceutical Industries Limited and Ursapharm Arzneimittel GmbH.

KEY BENEFITS FOR STAKEHOLDERS

  • The report provides an in-depth analysis of the global OTC artificial tears market size along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers market analysis from 2021 to 2028, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
  • A comprehensive analysis on region assists to understand the regional market and facilitate the strategic business planning and determine prevailing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global OTC artificial tears market.

KEY MARKET SEGMENTS

By Product

  • Solution
  • Ointment
  • Emulsion
  • Gel
  • Spray Solution
  • Suspensions

By Container Type

  • Plastic Single Dose Container
  • Plastic multi-dose containers
  • Preservative-Free System
  • Preserved System
  • Spray
  • Preservative-Free System
  • Preserved System

By Formulation

  • Preservative Based
  • Non-Preservative Based

By Application

  • Dry Eye Syndrome
  • Allergies
  • Infections
  • UV & Blue Light Protection
  • Contact Lens Moisture Retention
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Drug Store & Retail Pharmacies
  • Online Pharmacies

By Region

  • North America
  • U.S.
  • Rest of North America
  • Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Poland
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Malaysia
  • Thailand
  • Philippines
  • Rest of Asia-Pacific
  • Middle East
  • UAE
  • Saudi Arabia
  • Palestine
  • Jordan
  • Bahrain
  • Qatar
  • Azerbaijan
  • Georgia
  • Iraq
  • Pakistan
  • Kuwait
  • Israel
  • Kazakhstan
  • Rest of Middle East
  • North Africa
  • Morocco
  • Algeria
  • Tunisia
  • Libya
  • Egypt
  • Rest of North Africa
  • Rest of World

KEY MARKET PLAYERS

  • AbbVie, Inc.
  • Akorn, Inc.
  • Alcon
  • Bausch and Lamb
  • Johnson and Johnson
  • OcuSoft
  • Santen Pharmaceutical Co. Ltd
  • Similasan Corporation
  • Sun Pharmaceutical Industries Limited
  • Ursapharm Arzneimittel GmbH

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.REPORT DESCRIPTION
  • 1.2.KEY MARKET SEGMENTS
  • 1.3.KEY BENEFITS
  • 1.4.RESEARCH METHODOLOGY
    • 1.4.1.Primary research
    • 1.4.2.Secondary research
    • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.CXO PERSPECTIVE

CHAPTER 3:MARKET LANDSCAPE

  • 3.1.MARKET DEFINITION AND SCOPE
  • 3.2.KEY FINDINGS
    • 3.2.1.Top investment pockets
    • 3.2.2.Top winning strategies
  • 3.3.PORTER'S FIVE FORCES ANALYSIS
    • 3.3.1.Bargaining power of suppliers
    • 3.3.2.Threat of new entrants
    • 3.3.3.Threat of substitutes
    • 3.3.4.Competitive rivalry
    • 3.3.5.Bargaining power among buyers
  • 3.4.MARKET SHARE ANALYSIS/TOP PLAYER POSITIONING 2019
  • 3.5.MARKET DYNAMICS
    • 3.5.1.Drivers
    • 3.5.2.Restraints
    • 3.5.3.Opportunities
  • 3.6.IMPACT ANALYSIS OF COVID-19 ON MARKET

CHAPTER 4:OTC ARTIFICIAL TEARS MARKET BY PRODUCT TYPE

  • 4.1.OVERVIEW
  • 4.2.SOLUTION
    • 4.2.1.Key market trends, growth factors and opportunities
    • 4.2.2.Market size and forecast, by region
    • 4.2.3.Market share analysis, by country
  • 4.3.OINTMENT
    • 4.3.1.Key market trends, growth factors and opportunities
    • 4.3.2.Market size and forecast, by region
    • 4.3.3.Market share analysis, by country
  • 4.4.EMULSION
    • 4.4.1.Key market trends, growth factors and opportunities
    • 4.4.2.Market size and forecast, by region
    • 4.4.3.Market share analysis, by country
  • 4.5.GEL
    • 4.5.1.Key market trends, growth factors and opportunities
    • 4.5.2.Market size and forecast, by region
    • 4.5.3.Market share analysis, by country
  • 4.6.SPRAY SOLUTION
    • 4.6.1.Key market trends, growth factors and opportunities
    • 4.6.2.Market size and forecast, by region
    • 4.6.3.Market share analysis, by country
  • 4.7.SUSPENSIONS
    • 4.7.1.Key market trends, growth factors and opportunities
    • 4.7.2.Market size and forecast, by region
    • 4.7.3.Market share analysis, by country

CHAPTER 5:OTC ARTIFICIAL TEARS MARKET BY CONTAINER TYPE

  • 5.1.OVERVIEW
  • 5.2.PLASTIC SINGLE DOSE CONTAINER
    • 5.2.1.Key market trends, growth factors and opportunities
    • 5.2.2.Market size and forecast, by region
    • 5.2.3.Market share analysis, by country
  • 5.3.PLASTIC MULTI-DOSE CONTAINER
    • 5.3.1.Key market trends, growth factors and opportunities
    • 5.3.2.Market size and forecast, by region
    • 5.3.3.Market share analysis, by country
    • 5.3.4.Preservative-free system
      • 5.3.4.1.Market size and forecast
    • 5.3.5.Preserved Systems
      • 5.3.5.1.Market size and forecast
  • 5.4.SPRAY
    • 5.4.1.Key market trends, growth factors and opportunities
    • 5.4.2.Market size and forecast, by region
    • 5.4.3.Market share analysis, by country
    • 5.4.4.Preservative-free system
      • 5.4.4.1.Market size and forecast
    • 5.4.5.Preserved Systems
      • 5.4.5.1.Market size and forecast

CHAPTER 6:OTC ARTIFICIAL TEARS MARKET BY FORMULATION

  • 6.1.OVERVIEW
  • 6.2.PRESERVATIVE BASED
    • 6.2.1.Key market trends, growth factors and opportunities
    • 6.2.2.Market size and forecast, by region
    • 6.2.3.Market share analysis, by country
  • 6.3.NON-PRESERVATIVE BASED
    • 6.3.1.Key market trends, growth factors and opportunities
    • 6.3.2.Market size and forecast, by region
    • 6.3.3.Market share analysis, by country

CHAPTER 7:OTC ARTIFICIAL TEARS MARKET BY APPLICATION

  • 7.1.OVERVIEW
  • 7.2.DRY EYE SYNDROME
    • 7.2.1.Key market trends, growth factors and opportunities
    • 7.2.2.Market size and forecast, by region
    • 7.2.3.Market share analysis, by country
  • 7.3.ALLERGIES
    • 7.3.1.Key market trends, growth factors and opportunities
    • 7.3.2.Market size and forecast, by region
    • 7.3.3.Market share analysis, by country
  • 7.4.INFECTIONS
    • 7.4.1.Key market trends, growth factors and opportunities
    • 7.4.2.Market size and forecast, by region
    • 7.4.3.Market share analysis, by country
  • 7.5.UV AND BLUE LIGHT PROTECTION
    • 7.5.1.Key market trends, growth factors and opportunities
    • 7.5.2.Market size and forecast, by region
    • 7.5.3.Market share analysis, by country
  • 7.6.CONTACT LENS MOISTURE RETENTION
    • 7.6.1.Key market trends, growth factors and opportunities
    • 7.6.2.Market size and forecast, by region
    • 7.6.3.Market share analysis, by country
  • 7.7.OTHERS
    • 7.7.1.Key market trends, growth factors and opportunities
    • 7.7.2.Market size and forecast, by region
    • 7.7.3.Market share analysis, by country

CHAPTER 8:OTC ARTIFICIAL TEARS MARKET BY DISTRIBUTION CHANNEL

  • 8.1.OVERVIEW
  • 8.2.HOSPITAL PHARMACIES
    • 8.2.1.Key market trends, growth factors and opportunities
    • 8.2.2.Market size and forecast, by region
    • 8.2.3.Market share analysis, by country
  • 8.3.DRUG STORE AND RETAIL PHARMACIES
    • 8.3.1.Key market trends, growth factors and opportunities
    • 8.3.2.Market size and forecast, by region
    • 8.3.3.Market share analysis, by country
  • 8.4.ONLINE PHARMACIES
    • 8.4.1.Key market trends, growth factors and opportunities
    • 8.4.2.Market size and forecast, by region
    • 8.4.3.Market share analysis, by country

CHAPTER 9:OTC ARTIFICIAL TEARS MARKET BY REGION

  • 9.1.OVERVIEW
  • 9.2.NORTH AMERICA
    • 9.2.1.Key market trends and opportunities
    • 9.2.2.Market size and forecast, by product type
    • 9.2.3.Market size and forecast, by container type
    • 9.2.4.Market size and forecast, by formulation
    • 9.2.5.Market size and forecast, by application
    • 9.2.6.Market size and forecast, by distribution channel
    • 9.2.7.Market size and forecast, by Country
    • 9.2.8.U.S.
      • 9.2.8.1.Market size and forecast, by product type
      • 9.2.8.2.Market size and forecast, by container type
      • 9.2.8.3.Market size and forecast, by formulation
      • 9.2.8.4.Market size and forecast, by application
      • 9.2.8.5.Market size and forecast, by distribution channel
    • 9.2.9.Rest of North America
      • 9.2.9.1.Market size and forecast, by product type
      • 9.2.9.2.Market size and forecast, by container type
      • 9.2.9.3.Market size and forecast, by formulation
      • 9.2.9.4.Market size and forecast, by application
      • 9.2.9.5.Market size and forecast, by distribution channel
  • 9.3.EUROPE
    • 9.3.1.Key market trends and opportunities
    • 9.3.2.Market size and forecast, by product type
    • 9.3.3.Market size and forecast, by container type
    • 9.3.4.Market size and forecast, by formulation
    • 9.3.5.Market size and forecast, by application
    • 9.3.6.Market size and forecast, by distribution channel
    • 9.3.7.Market size and forecast, by Country
    • 9.3.8.UK
      • 9.3.8.1.Market size and forecast, by product type
      • 9.3.8.2.Market size and forecast, by container type
      • 9.3.8.3.Market size and forecast, by formulation
      • 9.3.8.4.Market size and forecast, by application
      • 9.3.8.5.Market size and forecast, by distribution channel
    • 9.3.9.Germany
      • 9.3.9.1.Market size and forecast, by product type
      • 9.3.9.2.Market size and forecast, by container type
      • 9.3.9.3.Market size and forecast, by formulation
      • 9.3.9.4.Market size and forecast, by application
      • 9.3.9.5.Market size and forecast, by distribution channel
    • 9.3.10.France
      • 9.3.10.1.Market size and forecast, by product type
      • 9.3.10.2.Market size and forecast, by container type
      • 9.3.10.3.Market size and forecast, by formulation
      • 9.3.10.4.Market size and forecast, by application
      • 9.3.10.5.Market size and forecast, by distribution channel
    • 9.3.11.Italy
      • 9.3.11.1.Market size and forecast, by product type
      • 9.3.11.2.Market size and forecast, by container type
      • 9.3.11.3.Market size and forecast, by formulation
      • 9.3.11.4.Market size and forecast, by application
      • 9.3.11.5.Market size and forecast, by distribution channel
    • 9.3.12.Spain
      • 9.3.12.1.Market size and forecast, by product type
      • 9.3.12.2.Market size and forecast, by container type
      • 9.3.12.3.Market size and forecast, by formulation
      • 9.3.12.4.Market size and forecast, by application
      • 9.3.12.5.Market size and forecast, by distribution channel
    • 9.3.13.Poland
      • 9.3.13.1.Market size and forecast, by product type
      • 9.3.13.2.Market size and forecast, by container type
      • 9.3.13.3.Market size and forecast, by formulation
      • 9.3.13.4.Market size and forecast, by application
      • 9.3.13.5.Market size and forecast, by distribution channel
    • 9.3.14.Rest of Europe
      • 9.3.14.1.Market size and forecast, by product type
      • 9.3.14.2.Market size and forecast, by container type
      • 9.3.14.3.Market size and forecast, by formulation
      • 9.3.14.4.Market size and forecast, by application
      • 9.3.14.5.Market size and forecast, by distribution channel
  • 9.4.ASIA-PACIFIC
    • 9.4.1.Key market trends and opportunities
    • 9.4.2.Market size and forecast, by product type
    • 9.4.3.Market size and forecast, by container type
    • 9.4.4.Market size and forecast, by formulation
    • 9.4.5.Market size and forecast, by application
    • 9.4.6.Market size and forecast, by distribution channel
    • 9.4.7.Market size and forecast, by Country
    • 9.4.8.Japan
      • 9.4.8.1.Market size and forecast, by product type
      • 9.4.8.2.Market size and forecast, by container type
      • 9.4.8.3.Market size and forecast, by formulation
      • 9.4.8.4.Market size and forecast, by application
      • 9.4.8.5.Market size and forecast, by distribution channel
    • 9.4.9.China
      • 9.4.9.1.Market size and forecast, by product type
      • 9.4.9.2.Market size and forecast, by container type
      • 9.4.9.3.Market size and forecast, by formulation
      • 9.4.9.4.Market size and forecast, by application
      • 9.4.9.5.Market size and forecast, by distribution channel
    • 9.4.10.India
      • 9.4.10.1.Market size and forecast, by product type
      • 9.4.10.2.Market size and forecast, by container type
      • 9.4.10.3.Market size and forecast, by formulation
      • 9.4.10.4.Market size and forecast, by application
      • 9.4.10.5.Market size and forecast, by distribution channel
    • 9.4.11.Malaysia
      • 9.4.11.1.Market size and forecast, by product type
      • 9.4.11.2.Market size and forecast, by container type
      • 9.4.11.3.Market size and forecast, by formulation
      • 9.4.11.4.Market size and forecast, by application
      • 9.4.11.5.Market size and forecast, by distribution channel
    • 9.4.12.Vietnam
      • 9.4.12.1.Market size and forecast, by product type
      • 9.4.12.2.Market size and forecast, by container type
      • 9.4.12.3.Market size and forecast, by formulation
      • 9.4.12.4.Market size and forecast, by application
      • 9.4.12.5.Market size and forecast, by distribution channel
    • 9.4.13.Thailand
      • 9.4.13.1.Market size and forecast, by product type
      • 9.4.13.2.Market size and forecast, by container type
      • 9.4.13.3.Market size and forecast, by formulation
      • 9.4.13.4.Market size and forecast, by application
      • 9.4.13.5.Market size and forecast, by distribution channel
    • 9.4.14.Philippines
      • 9.4.14.1.Market size and forecast, by product type
      • 9.4.14.2.Market size and forecast, by container type
      • 9.4.14.3.Market size and forecast, by formulation
      • 9.4.14.4.Market size and forecast, by application
      • 9.4.14.5.Market size and forecast, by distribution channel
    • 9.4.15.Rest of Asia-Pacific
      • 9.4.15.1.Market size and forecast, by product type
      • 9.4.15.2.Market size and forecast, by container type
      • 9.4.15.3.Market size and forecast, by formulation
      • 9.4.15.4.Market size and forecast, by application
      • 9.4.15.5.Market size and forecast, by distribution channel
  • 9.5.MIDDLE EAST
    • 9.5.1.Key market trends and opportunities
    • 9.5.2.Market size and forecast, by product type
    • 9.5.3.Market size and forecast, by container type
    • 9.5.4.Market size and forecast, by formulation
    • 9.5.5.Market size and forecast, by application
    • 9.5.6.Market size and forecast, by distribution channel
    • 9.5.7.Market size and forecast, by Country
    • 9.5.8.UAE
      • 9.5.8.1.Market size and forecast, by product type
      • 9.5.8.2.Market size and forecast, by container type
      • 9.5.8.3.Market size and forecast, by formulation
      • 9.5.8.4.Market size and forecast, by application
      • 9.5.8.5.Market size and forecast, by distribution channel
    • 9.5.9.Saudi Arabia
      • 9.5.9.1.Market size and forecast, by product type
      • 9.5.9.2.Market size and forecast, by container type
      • 9.5.9.3.Market size and forecast, by formulation
      • 9.5.9.4.Market size and forecast, by application
      • 9.5.9.5.Market size and forecast, by distribution channel
    • 9.5.10.Palestine
      • 9.5.10.1.Market size and forecast, by product type
      • 9.5.10.2.Market size and forecast, by container type
      • 9.5.10.3.Market size and forecast, by formulation
      • 9.5.10.4.Market size and forecast, by application
      • 9.5.10.5.Market size and forecast, by distribution channel
    • 9.5.11.Jordan
      • 9.5.11.1.Market size and forecast, by product type
      • 9.5.11.2.Market size and forecast, by container type
      • 9.5.11.3.Market size and forecast, by formulation
      • 9.5.11.4.Market size and forecast, by application
      • 9.5.11.5.Market size and forecast, by distribution channel
    • 9.5.12.Bahrein
      • 9.5.12.1.Market size and forecast, by product type
      • 9.5.12.2.Market size and forecast, by container type
      • 9.5.12.3.Market size and forecast, by formulation
      • 9.5.12.4.Market size and forecast, by application
      • 9.5.12.5.Market size and forecast, by distribution channel
    • 9.5.13.Qatar
      • 9.5.13.1.Market size and forecast, by product type
      • 9.5.13.2.Market size and forecast, by container type
      • 9.5.13.3.Market size and forecast, by formulation
      • 9.5.13.4.Market size and forecast, by application
      • 9.5.13.5.Market size and forecast, by distribution channel
    • 9.5.14.Azerbaijan
      • 9.5.14.1.Market size and forecast, by product type
      • 9.5.14.2.Market size and forecast, by container type
      • 9.5.14.3.Market size and forecast, by formulation
      • 9.5.14.4.Market size and forecast, by application
      • 9.5.14.5.Market size and forecast, by distribution channel
    • 9.5.15.Georgia
      • 9.5.15.1.Market size and forecast, by product type
      • 9.5.15.2.Market size and forecast, by container type
      • 9.5.15.3.Market size and forecast, by formulation
      • 9.5.15.4.Market size and forecast, by application
      • 9.5.15.5.Market size and forecast, by distribution channel
    • 9.5.16.Iraq
      • 9.5.16.1.Market size and forecast, by product type
      • 9.5.16.2.Market size and forecast, by container type
      • 9.5.16.3.Market size and forecast, by formulation
      • 9.5.16.4.Market size and forecast, by application
      • 9.5.16.5.Market size and forecast, by distribution channel
    • 9.5.17.Pakistan
      • 9.5.17.1.Market size and forecast, by product type
      • 9.5.17.2.Market size and forecast, by container type
      • 9.5.17.3.Market size and forecast, by formulation
      • 9.5.17.4.Market size and forecast, by application
      • 9.5.17.5.Market size and forecast, by distribution channel
    • 9.5.18.Kuwait
      • 9.5.18.1.Market size and forecast, by product type
      • 9.5.18.2.Market size and forecast, by container type
      • 9.5.18.3.Market size and forecast, by formulation
      • 9.5.18.4.Market size and forecast, by application
      • 9.5.18.5.Market size and forecast, by distribution channel
    • 9.5.19.Israel
      • 9.5.19.1.Market size and forecast, by product type
      • 9.5.19.2.Market size and forecast, by container type
      • 9.5.19.3.Market size and forecast, by formulation
      • 9.5.19.4.Market size and forecast, by application
      • 9.5.19.5.Market size and forecast, by distribution channel
    • 9.5.20.Kazakhstan
      • 9.5.20.1.Market size and forecast, by product type
      • 9.5.20.2.Market size and forecast, by container type
      • 9.5.20.3.Market size and forecast, by formulation
      • 9.5.20.4.Market size and forecast, by application
      • 9.5.20.5.Market size and forecast, by distribution channel
    • 9.5.21.Rest of Middle East
      • 9.5.21.1.Market size and forecast, by product type
      • 9.5.21.2.Market size and forecast, by container type
      • 9.5.21.3.Market size and forecast, by formulation
      • 9.5.21.4.Market size and forecast, by application
      • 9.5.21.5.Market size and forecast, by distribution channel
  • 9.6.NORTH AFRICA
    • 9.6.1.Key market trends and opportunities
    • 9.6.2.Market size and forecast, by product type
    • 9.6.3.Market size and forecast, by container type
    • 9.6.4.Market size and forecast, by formulation
    • 9.6.5.Market size and forecast, by application
    • 9.6.6.Market size and forecast, by distribution channel
    • 9.6.7.Market size and forecast, by Country
    • 9.6.8.Morocco
      • 9.6.8.1.Market size and forecast, by product type
      • 9.6.8.2.Market size and forecast, by container type
      • 9.6.8.3.Market size and forecast, by formulation
      • 9.6.8.4.Market size and forecast, by application
      • 9.6.8.5.Market size and forecast, by distribution channel
    • 9.6.9.Algeria
      • 9.6.9.1.Market size and forecast, by product type
      • 9.6.9.2.Market size and forecast, by container type
      • 9.6.9.3.Market size and forecast, by formulation
      • 9.6.9.4.Market size and forecast, by application
      • 9.6.9.5.Market size and forecast, by distribution channel
    • 9.6.10.Tunisia
      • 9.6.10.1.Market size and forecast, by product type
      • 9.6.10.2.Market size and forecast, by container type
      • 9.6.10.3.Market size and forecast, by formulation
      • 9.6.10.4.Market size and forecast, by application
      • 9.6.10.5.Market size and forecast, by distribution channel
    • 9.6.11.Libia
      • 9.6.11.1.Market size and forecast, by product type
      • 9.6.11.2.Market size and forecast, by container type
      • 9.6.11.3.Market size and forecast, by formulation
      • 9.6.11.4.Market size and forecast, by application
      • 9.6.11.5.Market size and forecast, by distribution channel
    • 9.6.12.Egypt
      • 9.6.12.1.Market size and forecast, by product type
      • 9.6.12.2.Market size and forecast, by container type
      • 9.6.12.3.Market size and forecast, by formulation
      • 9.6.12.4.Market size and forecast, by application
      • 9.6.12.5.Market size and forecast, by distribution channel
    • 9.6.13.Rest of North Africa
      • 9.6.13.1.Market size and forecast, by product type
      • 9.6.13.2.Market size and forecast, by container type
      • 9.6.13.3.Market size and forecast, by formulation
      • 9.6.13.4.Market size and forecast, by application
      • 9.6.13.5.Market size and forecast, by distribution channel

CHAPTER 10:COMPANY PROFILES

  • 10.1.SANTEN PHARMACEUTICAL
    • 10.1.1.Company overview
    • 10.1.2.Key Executives
    • 10.1.3.Company snapshot
    • 10.1.4.Operating business segments
    • 10.1.5.Product portfolio
    • 10.1.6.Business performance
    • 10.1.7.Key strategic moves and developments
  • 10.2.BAUSCH & LOMB
    • 10.2.1.Company overview
    • 10.2.2.Key Executives
    • 10.2.3.Company snapshot
    • 10.2.4.Operating business segments
    • 10.2.5.Product portfolio
    • 10.2.6.Business performance
    • 10.2.7.Key strategic moves and developments
  • 10.3.ALLERGAN
    • 10.3.1.Company overview
    • 10.3.2.Key Executives
    • 10.3.3.Company snapshot
    • 10.3.4.Operating business segments
    • 10.3.5.Product portfolio
    • 10.3.6.Business performance
    • 10.3.7.Key strategic moves and developments
  • 10.4.ABBOTT LABORATORIES
    • 10.4.1.Company overview
    • 10.4.2.Key Executives
    • 10.4.3.Company snapshot
    • 10.4.4.Operating business segments
    • 10.4.5.Product portfolio
    • 10.4.6.Business performance
    • 10.4.7.Key strategic moves and developments
  • 10.5.JOHNSON & JOHNSON
    • 10.5.1.Company overview
    • 10.5.2.Key Executives
    • 10.5.3.Company snapshot
    • 10.5.4.Operating business segments
    • 10.5.5.Product portfolio
    • 10.5.6.Business performance
    • 10.5.7.Key strategic moves and developments
  • 10.6.LUMECARE
    • 10.6.1.Company overview
    • 10.6.2.Key Executives
    • 10.6.3.Company snapshot
    • 10.6.4.Operating business segments
    • 10.6.5.Product portfolio
    • 10.6.6.Business performance
    • 10.6.7.Key strategic moves and developments
  • 10.7.SIMILASAN CORPORATION
    • 10.7.1.Company overview
    • 10.7.2.Key Executives
    • 10.7.3.Company snapshot
    • 10.7.4.Operating business segments
    • 10.7.5.Product portfolio
    • 10.7.6.Business performance
    • 10.7.7.Key strategic moves and developments
  • 10.8.URSAPHARM
    • 10.8.1.Company overview
    • 10.8.2.Key Executives
    • 10.8.3.Company snapshot
    • 10.8.4.Operating business segments
    • 10.8.5.Product portfolio
    • 10.8.6.Business performance
    • 10.8.7.Key strategic moves and developments
  • 10.9.NOVARTIS AG (ALCON)
    • 10.9.1.Company overview
    • 10.9.2.Key Executives
    • 10.9.3.Company snapshot
    • 10.9.4.Operating business segments
    • 10.9.5.Product portfolio
    • 10.9.6.Business performance
    • 10.9.7.Key strategic moves and developments
  • 10.10.OCUSOFT
    • 10.10.1.Company overview
    • 10.10.2.Key Executives
    • 10.10.3.Company snapshot
    • 10.10.4.Operating business segments
    • 10.10.5.Product portfolio
    • 10.10.6.Business performance
    • 10.10.7.Key strategic moves and developments

LIST OF TABLES

  • TABLE 1.GLOBAL OTC ARTIFICIAL TEARS MARKET, BY PRODUCT TYPE 2019-2027 ($MILLION)
  • TABLE 2.OTC ARTIFICIAL TEARS MARKET FOR SOLUTION, BY REGION, 2019-2027 ($MILLION)
  • TABLE 3.OTC ARTIFICIAL TEARS MARKET FOR OINTMENT, BY REGION, 2019-2027 ($MILLION)
  • TABLE 4.OTC ARTIFICIAL TEARS MARKET FOR EMULSION, BY REGION, 2019-2027 ($MILLION)
  • TABLE 5.OTC ARTIFICIAL TEARS MARKET FOR GEL, BY REGION, 2019-2027 ($MILLION)
  • TABLE 6.OTC ARTIFICIAL TEARS MARKET FOR SPRAY SOLUTION, BY REGION, 2019-2027 ($MILLION)
  • TABLE 7.OTC ARTIFICIAL TEARS MARKET FOR SUSPENSIONS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 8.GLOBAL OTC ARTIFICIAL TEARS MARKET, BY CONTAINER TYPE 2019-2027 ($MILLION)
  • TABLE 9.OTC ARTIFICIAL TEARS MARKET FOR PLASTIC SINGLE DOSE CONTAINER, BY REGION, 2019-2027 ($MILLION)
  • TABLE 10.OTC ARTIFICIAL TEARS MARKET FOR PLASTIC MULTI-DOSE CONTAINER, BY REGION, 2019-2027 ($MILLION)
  • TABLE 11.OTC ARTIFICIAL TEARS MARKET FOR PRESERVATIVE-FREE SYSTEM, BY REGION, 2019-2027 ($MILLION)
  • TABLE 12.OTC ARTIFICIAL TEARS MARKET FOR PRESERVED SYSTEMS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 13.OTC ARTIFICIAL TEARS MARKET FOR SPRAY, BY REGION, 2019-2027 ($MILLION)
  • TABLE 14.OTC ARTIFICIAL TEARS MARKET FOR PRESERVATIVE-FREE SYSTEM, BY REGION, 2019-2027 ($MILLION)
  • TABLE 15.OTC ARTIFICIAL TEARS MARKET FOR PRESERVED SYSTEMS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 16.GLOBAL OTC ARTIFICIAL TEARS MARKET, BY FORMULATION 2019-2027 ($MILLION)
  • TABLE 17.OTC ARTIFICIAL TEARS MARKET FOR PRESERVATIVE BASED, BY REGION, 2019-2027 ($MILLION)
  • TABLE 18.OTC ARTIFICIAL TEARS MARKET FOR NON-PRESERVATIVE BASED, BY REGION, 2019-2027 ($MILLION)
  • TABLE 19.GLOBAL OTC ARTIFICIAL TEARS MARKET, BY APPLICATION 2019-2027 ($MILLION)
  • TABLE 20.OTC ARTIFICIAL TEARS MARKET FOR DRY EYE SYNDROME, BY REGION, 2019-2027 ($MILLION)
  • TABLE 21.OTC ARTIFICIAL TEARS MARKET FOR ALLERGIES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 22.OTC ARTIFICIAL TEARS MARKET FOR INFECTIONS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 23.OTC ARTIFICIAL TEARS MARKET FOR UV AND BLUE LIGHT PROTECTION, BY REGION, 2019-2027 ($MILLION)
  • TABLE 24.OTC ARTIFICIAL TEARS MARKET FOR CONTACT LENS MOISTURE RETENTION, BY REGION, 2019-2027 ($MILLION)
  • TABLE 25.OTC ARTIFICIAL TEARS MARKET FOR OTHERS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 26.GLOBAL OTC ARTIFICIAL TEARS MARKET, BY DISTRIBUTION CHANNEL 2019-2027 ($MILLION)
  • TABLE 27.OTC ARTIFICIAL TEARS MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 28.OTC ARTIFICIAL TEARS MARKET FOR DRUG STORE AND RETAIL PHARMACIES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 29.OTC ARTIFICIAL TEARS MARKET FOR ONLINE PHARMACIES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 30.OTC ARTIFICIAL TEARS MARKET FOR , BY REGION, , 2019-2027 ($MILLION)
  • TABLE 31.NORTH AMERICA OTC ARTIFICIAL TEARS, BY PRODUCT TYPE 2019-2027 ($MILLION)
  • TABLE 32.NORTH AMERICA OTC ARTIFICIAL TEARS, BY CONTAINER TYPE 2019-2027 ($MILLION)
  • TABLE 33.NORTH AMERICA OTC ARTIFICIAL TEARS, BY FORMULATION 2019-2027 ($MILLION)
  • TABLE 34.NORTH AMERICA OTC ARTIFICIAL TEARS, BY APPLICATION 2019-2027 ($MILLION)
  • TABLE 35.NORTH AMERICA OTC ARTIFICIAL TEARS, BY DISTRIBUTION CHANNEL 2019-2027 ($MILLION)
  • TABLE 36.NORTH AMERICA OTC ARTIFICIAL TEARS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 37.EUROPE OTC ARTIFICIAL TEARS, BY PRODUCT TYPE 2019-2027 ($MILLION)
  • TABLE 38.EUROPE OTC ARTIFICIAL TEARS, BY CONTAINER TYPE 2019-2027 ($MILLION)
  • TABLE 39.EUROPE OTC ARTIFICIAL TEARS, BY FORMULATION 2019-2027 ($MILLION)
  • TABLE 40.EUROPE OTC ARTIFICIAL TEARS, BY APPLICATION 2019-2027 ($MILLION)
  • TABLE 41.EUROPE OTC ARTIFICIAL TEARS, BY DISTRIBUTION CHANNEL 2019-2027 ($MILLION)
  • TABLE 42.EUROPE OTC ARTIFICIAL TEARS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 43.ASIA-PACIFIC OTC ARTIFICIAL TEARS, BY PRODUCT TYPE 2019-2027 ($MILLION)
  • TABLE 44.ASIA-PACIFIC OTC ARTIFICIAL TEARS, BY CONTAINER TYPE 2019-2027 ($MILLION)
  • TABLE 45.ASIA-PACIFIC OTC ARTIFICIAL TEARS, BY FORMULATION 2019-2027 ($MILLION)
  • TABLE 46.ASIA-PACIFIC OTC ARTIFICIAL TEARS, BY APPLICATION 2019-2027 ($MILLION)
  • TABLE 47.ASIA-PACIFIC OTC ARTIFICIAL TEARS, BY DISTRIBUTION CHANNEL 2019-2027 ($MILLION)
  • TABLE 48.ASIA-PACIFIC OTC ARTIFICIAL TEARS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 49.MIDDLE EAST OTC ARTIFICIAL TEARS, BY PRODUCT TYPE 2019-2027 ($MILLION)
  • TABLE 50.MIDDLE EAST OTC ARTIFICIAL TEARS, BY CONTAINER TYPE 2019-2027 ($MILLION)
  • TABLE 51.MIDDLE EAST OTC ARTIFICIAL TEARS, BY FORMULATION 2019-2027 ($MILLION)
  • TABLE 52.MIDDLE EAST OTC ARTIFICIAL TEARS, BY APPLICATION 2019-2027 ($MILLION)
  • TABLE 53.MIDDLE EAST OTC ARTIFICIAL TEARS, BY DISTRIBUTION CHANNEL 2019-2027 ($MILLION)
  • TABLE 54.MIDDLE EAST OTC ARTIFICIAL TEARS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 55.NORTH AFRICA OTC ARTIFICIAL TEARS, BY PRODUCT TYPE 2019-2027 ($MILLION)
  • TABLE 56.NORTH AFRICA OTC ARTIFICIAL TEARS, BY CONTAINER TYPE 2019-2027 ($MILLION)
  • TABLE 57.NORTH AFRICA OTC ARTIFICIAL TEARS, BY FORMULATION 2019-2027 ($MILLION)
  • TABLE 58.NORTH AFRICA OTC ARTIFICIAL TEARS, BY APPLICATION 2019-2027 ($MILLION)
  • TABLE 59.NORTH AFRICA OTC ARTIFICIAL TEARS, BY DISTRIBUTION CHANNEL 2019-2027 ($MILLION)
  • TABLE 60.NORTH AFRICA OTC ARTIFICIAL TEARS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 61.SANTEN PHARMACEUTICAL: COMPANY SNAPSHOT
  • TABLE 62.SANTEN PHARMACEUTICAL: OPERATING SEGMENTS
  • TABLE 63.BAUSCH & LOMB: COMPANY SNAPSHOT
  • TABLE 64.BAUSCH & LOMB: OPERATING SEGMENTS
  • TABLE 65.ALLERGAN: COMPANY SNAPSHOT
  • TABLE 66.ALLERGAN: OPERATING SEGMENTS
  • TABLE 67.ABBOTT LABORATORIES: COMPANY SNAPSHOT
  • TABLE 68.ABBOTT LABORATORIES: OPERATING SEGMENTS
  • TABLE 69.JOHNSON & JOHNSON: COMPANY SNAPSHOT
  • TABLE 70.JOHNSON & JOHNSON: OPERATING SEGMENTS
  • TABLE 71.LUMECARE: COMPANY SNAPSHOT
  • TABLE 72.LUMECARE: OPERATING SEGMENTS
  • TABLE 73.SIMILASAN CORPORATION: COMPANY SNAPSHOT
  • TABLE 74.SIMILASAN CORPORATION: OPERATING SEGMENTS
  • TABLE 75.URSAPHARM: COMPANY SNAPSHOT
  • TABLE 76.URSAPHARM: OPERATING SEGMENTS
  • TABLE 77.NOVARTIS AG (ALCON): COMPANY SNAPSHOT
  • TABLE 78.NOVARTIS AG (ALCON): OPERATING SEGMENTS
  • TABLE 79.OCUSOFT: COMPANY SNAPSHOT
  • TABLE 80.OCUSOFT: OPERATING SEGMENTS

LIST OF FIGURES

  • FIGURE 1.GLOBAL OTC ARTIFICIAL TEARS MARKET SEGMENTATION
  • FIGURE 2.TOP INVESTMENT POCKET
  • FIGURE 3.TOP WINNING STRATEGIES (%)
  • FIGURE 4.OTC ARTIFICIAL TEARS MARKET FOR SOLUTION, 2019-2027 ($MILLION)
  • FIGURE 5.OTC ARTIFICIAL TEARS MARKET FOR OINTMENT, 2019-2027 ($MILLION)
  • FIGURE 6.OTC ARTIFICIAL TEARS MARKET FOR EMULSION, 2019-2027 ($MILLION)
  • FIGURE 7.OTC ARTIFICIAL TEARS MARKET FOR GEL, 2019-2027 ($MILLION)
  • FIGURE 8.OTC ARTIFICIAL TEARS MARKET FOR SPRAY SOLUTION, 2019-2027 ($MILLION)
  • FIGURE 9.OTC ARTIFICIAL TEARS MARKET FOR SUSPENSIONS, 2019-2027 ($MILLION)
  • FIGURE 10.OTC ARTIFICIAL TEARS MARKET FOR PLASTIC SINGLE DOSE CONTAINER, 2019-2027 ($MILLION)
  • FIGURE 11.OTC ARTIFICIAL TEARS MARKET FOR PLASTIC MULTI-DOSE CONTAINER, 2019-2027 ($MILLION)
  • FIGURE 12.OTC ARTIFICIAL TEARS MARKET FOR SPRAY, 2019-2027 ($MILLION)
  • FIGURE 13.OTC ARTIFICIAL TEARS MARKET FOR PRESERVATIVE BASED, 2019-2027 ($MILLION)
  • FIGURE 14.OTC ARTIFICIAL TEARS MARKET FOR NON-PRESERVATIVE BASED, 2019-2027 ($MILLION)
  • FIGURE 15.OTC ARTIFICIAL TEARS MARKET FOR DRY EYE SYNDROME, 2019-2027 ($MILLION)
  • FIGURE 16.OTC ARTIFICIAL TEARS MARKET FOR ALLERGIES, 2019-2027 ($MILLION)
  • FIGURE 17.OTC ARTIFICIAL TEARS MARKET FOR INFECTIONS, 2019-2027 ($MILLION)
  • FIGURE 18.OTC ARTIFICIAL TEARS MARKET FOR UV AND BLUE LIGHT PROTECTION, 2019-2027 ($MILLION)
  • FIGURE 19.OTC ARTIFICIAL TEARS MARKET FOR CONTACT LENS MOISTURE RETENTION, 2019-2027 ($MILLION)
  • FIGURE 20.OTC ARTIFICIAL TEARS MARKET FOR OTHERS, 2019-2027 ($MILLION)
  • FIGURE 21.OTC ARTIFICIAL TEARS MARKET FOR HOSPITAL PHARMACIES, 2019-2027 ($MILLION)
  • FIGURE 22.OTC ARTIFICIAL TEARS MARKET FOR DRUG STORE AND RETAIL PHARMACIES, 2019-2027 ($MILLION)
  • FIGURE 23.OTC ARTIFICIAL TEARS MARKET FOR ONLINE PHARMACIES, 2019-2027 ($MILLION)
  • FIGURE 24.GLOBAL OTC ARTIFICIAL TEARS, BY REGION, 2019 (%)
  • FIGURE 25.U.S. OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 26.REST OF NORTH AMERICA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 27.UK OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 28.GERMANY OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 29.FRANCE OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 30.ITALY OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 31.SPAIN OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 32.POLAND OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 33.REST OF EUROPE OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 34.JAPAN OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 35.CHINA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 36.INDIA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 37.MALAYSIA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 38.VIETNAM OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 39.THAILAND OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 40.PHILIPPINES OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 41.REST OF ASIA-PACIFIC OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 42.UAE OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 43.SAUDI ARABIA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 44.PALESTINE OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 45.JORDAN OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 46.BAHREIN OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 47.QATAR OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 48.AZERBAIJAN OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 49.GEORGIA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 50.IRAQ OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 51.PAKISTAN OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 52.KUWAIT OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 53.ISRAEL OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 54.KAZAKHSTAN OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 55.REST OF MIDDLE EAST OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 56.MOROCCO OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 57.ALGERIA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 58.TUNISIA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 59.LIBIA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 60.EGYPT OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)
  • FIGURE 61.REST OF NORTH AFRICA OTC ARTIFICIAL TEARS MARKET, 2019-2027 ($MILLION)